Published:
Scottsdale, Arizona, United States - October 5, 2024
Blue Goat Cyber, a leader in medical device cybersecurity solutions, is excited to announce its successful participation in two major global events: LSI Europe 2024 in Sintra, Portugal, and RAPS Convergence 2024 in Long Beach, California. These engagements mark a significant step in the company’s ongoing global expansion, positioning Blue Goat Cyber as a trusted partner for medical device manufacturers, CROs, and strategic partners worldwide.
At LSI Europe 2024, Blue Goat Cyber held 70 one-on-one meetings with innovators, CROs, and strategic partners. These high-impact meetings focused on cybersecurity challenges, compliance solutions, and collaborative opportunities to secure medical technologies. Meanwhile, at RAPS Convergence 2024, Blue Goat Cyber hosted a booth where regulatory professionals and manufacturers explored the company’s comprehensive cybersecurity services, designed to help ensure compliance with FDA, MDR, and IVDR regulations.
“ Our participation at LSI Europe and RAPS Convergence was a major success,” said Christian Espinosa, CEO of Blue Goat Cyber. “ The discussions at LSI Europe allowed us to forge strong partnerships, while our booth at RAPS Convergence enabled us to showcase our expertise in helping manufacturers meet global cybersecurity standards.”
Global Expansion and Future Growth:
With increasing cybersecurity demands in the medical device sector, Blue Goat Cyber is expanding its global operations to provide localized support for manufacturers worldwide. This continued growth reflects the company’s commitment to delivering tailored cybersecurity solutions that ensure device safety, compliance, and market readiness.
About Blue Goat Cyber:
Blue Goat Cyber is a specialized cybersecurity consulting firm focused on medical device security and regulatory compliance. The company offers services such as penetration testing, security risk management, and postmarket surveillance to help manufacturers meet stringent cybersecurity requirements from regulatory bodies like the FDA and EU MDR/IVDR.